Evidence map›Paper›PMID 42738763›Full record

ArticleMolecules (Basel, Switzerland)2026

Fungal-Based Biogenic Silver Nanoparticles: Synthesis, Mathematical Modeling and Application.

Alejandra Ortiz-Tirado, Erick R Bandala, Victor H Robledo-Zacarias, Alain S Conejo-Davila, Alejandro Vega-Rios, James McGree, Luis Fernando Mejia-Diaz, Ashantha Goonetilleke, Martín Pacheco-Álvarez, Oscar M Rodriguez-Narvaez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alejandra Ortiz-TiradoDirection of Applied Research and Development, Center for Applied Innovation in Competitive Technologies, Omega 201, León 37545, Guanajuato, Mexico.ORCID 0009-0009-4246-7315
Erick R BandalaNantBioRenewables LLC, 100 Seapoint Blv. Bldg 5, Savannah, GA 31404, USA.
Victor H Robledo-ZacariasTechnological Solutions Department, Center for Applied Innovation in Competitive Technologies, Omega 201, León 37545, Guanajuato, Mexico.ORCID 0000-0001-6894-2801
Alain S Conejo-DavilaMicroPrime S RL de CV, El Colorado, Santiago de Querétaro 76246, Querétaro, Mexico.
Alejandro Vega-RiosCentro de Investigación en Materiales Avanzados, S.C. (CIMAV), Miguel de Cervantes No. 120, Chihuahua 31136, Chihuahua, Mexico.ORCID 0000-0002-9156-4703
James McGreeSchool of Mathematical Sciences, Queensland University of Technology, GPO Box 2344, Brisbane, QLD 4001, Australia.
Luis Fernando Mejia-DiazTransdisciplinary Institute of Research and Services (ITRANS), University of Guadalajara, Zapopan 45150, Jalisco, Mexico.ORCID 0000-0003-3312-140X
Ashantha GoonetillekeDepartment of Civil Engineering, Birla Institute of Technology and Science, Pilani Campus, Vidya Vihar, Pilani 333031, Rajasthan, India.
Martín Pacheco-ÁlvarezDepartamento de Química-DCNE, Universidad de Guanajuato, Cerro de la Venada s/n, Pueblito de Rocha, Guanajuato 36040, Guanajuato, Mexico.ORCID 0000-0002-2283-5741
Oscar M Rodriguez-NarvaezDirection of Applied Research and Development, Center for Applied Innovation in Competitive Technologies, Omega 201, León 37545, Guanajuato, Mexico.ORCID 0000-0002-9943-9261

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biogenic synthesis based on microorganisms and plants utilizes biomolecules and metabolites that act as reducing and stabilizing agents. Furthermore, these biomolecules confer enhanced properties, increasing their effectiveness as antibacterial agents, even against multidrug-resistant bacteria. However, there is currently a lack of knowledge regarding the characteristics of the biomolecules involved and their mechanisms during synthesis, which limits their wider application. This research study focused on the synthesis of AgNPs using extracellularly secreted biomolecules from the filamentous fungus

Indexed as

Anti-Bacterial AgentsFungiMetal NanoparticlesModels, TheoreticalSilverEscherichia coliMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsSilverbiogenic synthesisbiomoleculesdisinfectionfilamentous fungussilver nanoparticles

Identifiers

PMID42738763
PMCPMC13566992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.